Correspondence 0001193125-24-012244 from CG Oncology, Inc. (CGON) (CIK 0001991792) (CGON)
CG Oncology, Inc. (CGON) (CIK 0001991792)
Date: Jan. 22, 2024 · CIK: 0001991792 · Accession: 0001193125-24-012244
AI Filing Summary & Sentiment
File numbers found in text: 333-276350
Show Raw Text
CORRESP 1 filename1.htm CORRESP January 22, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Jimmy McNamara Re: CG Oncology, Inc. (the “Registrant”) Registration Statement on Form S-1 (File No. 333-276350) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between January 18, 2024 and the date hereof, approximately 3,150 copies of the Preliminary Prospectus, dated January 18, 2024, were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement, as amended. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the Registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, January 24, 2024 or as soon thereafter as practicable. [signature page follows] Very truly yours, MORGAN STANLEY & CO. LLC GOLDMAN SACHS & CO. LLC CANTOR FITZGERALD & CO. As representatives of the Underwriters MORGAN STANLEY & CO. LLC By: /s/ Chirag Surti Name: Chirag Surti Title: Executive Director GOLDMAN SACHS & CO. LLC By: /s/ Danielle Freeman Name: Danielle Freeman Title: Managing Director CANTOR FITZGERALD & CO. By: /s/ Sage Kelly Name: Sage Kelly Title: Senior Managing Director [Signature Page to Acceleration Request Letter]